Search research articles
Contact Us
Filters
Showing results (11-20 of 66) with videos related to
Page
of 7
Sort By:
Breast Cancer Research and Treatment
|
November 29, 2007
TGFbeta2 and TbetaRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cells
Miriam B Buck, Janet K Coller, Thomas E Mürdter, et al.
British Journal of Clinical Pharmacology
|
June 21, 2019
The impact of liver transplant recipient and donor genetic variability on tacrolimus exposure and transplant outcome
Janet K Coller, Jeyamani Ramachandran, Libby John, et al.
Brain, Behavior, and Immunity
|
March 31, 2011
Naloxone-precipitated morphine withdrawal behavior and brain IL-1β expression: comparison of different mouse strains
Liang Liu, Janet K Coller, Linda R Watkins, et al.
Pharmacogenetics and Genomics
|
November 30, 2018
Effect of tacrolimus dispositional genetics on acute rejection in the first 2 weeks and estimated glomerular filtration rate in the first 3 months following kidney transplantation
Rong Hu, Daniel T Barratt, Janet K Coller, et al.
Pharmacogenetics and Genomics
|
October 6, 2009
Association of IL-1B genetic polymorphisms with an increased risk of opioid and alcohol dependence
Liang Liu, Mark R Hutchinson, Jason M White, et al.
Therapeutic Drug Monitoring
|
July 2, 2019
Is There a Temporal Relationship Between Trough Whole Blood Tacrolimus Concentration and Acute Rejection in the First 14 Days After Kidney Transplantation?
Rong Hu, Daniel T Barratt, Janet K Coller, et al.
Frontiers in Pharmacology
|
March 11, 2020
No Major Effect of Innate Immune Genetics on Acute Kidney Rejection in the First 2 Weeks Post-Transplantation
Rong Hu, Daniel T Barratt, Janet K Coller, et al.
Clinical Pharmacology and Therapeutics
|
December 21, 2006
ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals
Janet K Coller, Daniel T Barratt, Karianne Dahlen, et al.
Basic & Clinical Pharmacology & Toxicology
|
April 1, 2018
CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose-adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post-Kidney Transplantation
Rong Hu, Daniel T Barratt, Janet K Coller, et al.
Journal of Cancer Research and Clinical Oncology
|
July 16, 2022
Contribution of TLR4 to colorectal tumor microenvironment, etiology and prognosis
Elise E Crame, Saeed Nourmohammadi, Hannah R Wardill, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 66) with videos related to
Sort By:
Page
of 7
Breast Cancer Research and Treatment
|
November 29, 2007
TGFbeta2 and TbetaRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cells
Miriam B Buck, Janet K Coller, Thomas E Mürdter, et al.
British Journal of Clinical Pharmacology
|
June 21, 2019
The impact of liver transplant recipient and donor genetic variability on tacrolimus exposure and transplant outcome
Janet K Coller, Jeyamani Ramachandran, Libby John, et al.
Brain, Behavior, and Immunity
|
March 31, 2011
Naloxone-precipitated morphine withdrawal behavior and brain IL-1β expression: comparison of different mouse strains
Liang Liu, Janet K Coller, Linda R Watkins, et al.
Pharmacogenetics and Genomics
|
November 30, 2018
Effect of tacrolimus dispositional genetics on acute rejection in the first 2 weeks and estimated glomerular filtration rate in the first 3 months following kidney transplantation
Rong Hu, Daniel T Barratt, Janet K Coller, et al.
Pharmacogenetics and Genomics
|
October 6, 2009
Association of IL-1B genetic polymorphisms with an increased risk of opioid and alcohol dependence
Liang Liu, Mark R Hutchinson, Jason M White, et al.
Therapeutic Drug Monitoring
|
July 2, 2019
Is There a Temporal Relationship Between Trough Whole Blood Tacrolimus Concentration and Acute Rejection in the First 14 Days After Kidney Transplantation?
Rong Hu, Daniel T Barratt, Janet K Coller, et al.
Frontiers in Pharmacology
|
March 11, 2020
No Major Effect of Innate Immune Genetics on Acute Kidney Rejection in the First 2 Weeks Post-Transplantation
Rong Hu, Daniel T Barratt, Janet K Coller, et al.
Clinical Pharmacology and Therapeutics
|
December 21, 2006
ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals
Janet K Coller, Daniel T Barratt, Karianne Dahlen, et al.
Basic & Clinical Pharmacology & Toxicology
|
April 1, 2018
CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose-adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post-Kidney Transplantation
Rong Hu, Daniel T Barratt, Janet K Coller, et al.
Journal of Cancer Research and Clinical Oncology
|
July 16, 2022
Contribution of TLR4 to colorectal tumor microenvironment, etiology and prognosis
Elise E Crame, Saeed Nourmohammadi, Hannah R Wardill, et al.
Page
of 7